# HCW Biologics (HCWB) — Earnings

HCWB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/hcwb/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$40.74 |
| EPS estimate | $10.80 |
| EPS surprise | −477.22% |
| Revenue surprise | −99.98% |
| Revenue | $1,310.00 |
| Revenue estimate | $7.0M |
| Reported | Aug 14, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1828673/000095017025109642/hcwb-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 14, 2025 | $10.80 | −$40.74 | -477.22% | $7.0M | $1,310.00 |
| Q1 2025 | May 15, 2025 | $0.00 | −$12.00 | 0.00% | — | $5,065.00 |
| Q4 2024 | Mar 28, 2025 | $21.60 | −$19.20 | -188.89% | $7.0M | $394,804.00 |
| Q3 2024 | Nov 14, 2024 | −$31.20 | −$24.00 | 23.08% | — | $852,850.00 |
| Q2 2024 | Aug 14, 2024 | −$43.20 | −$1.08 | 97.50% | — | $618,854.00 |
| Q1 2024 | May 15, 2024 | $0.00 | −$48.00 | 0.00% | — | $614,747.00 |
| Q4 2023 | Apr 1, 2024 | −$34.80 | −$72.00 | -106.90% | $900,000.00 | $1.3M |
| Q3 2023 | Nov 14, 2023 | −$31.20 | −$33.60 | -7.69% | $600,000.00 | $853,102.00 |
| Q2 2023 | Aug 11, 2023 | −$36.00 | −$28.80 | 20.00% | — | $622,807.00 |
| Q1 2023 | May 9, 2023 | −$33.60 | −$33.60 | 0.00% | $2.3M | $41,883.00 |
| Q4 2022 | Mar 28, 2023 | −$36.80 | −$36.00 | 2.17% | — | $1.3M |
| Q3 2022 | Nov 7, 2022 | −$31.20 | −$26.40 | 15.38% | — | $1.8M |
| Q2 2022 | Aug 12, 2022 | −$30.00 | −$24.00 | 20.00% | — | $454,000.00 |
| Q1 2022 | May 13, 2022 | −$26.40 | −$14.40 | 45.45% | — | $1.8M |
| Q4 2021 | Mar 28, 2022 | −$28.80 | −$21.60 | 25.00% | — | — |

## Frequently Asked Questions

### When did HCW Biologics (HCWB) last report earnings?

HCW Biologics last reported on Aug 14, 2025, covering fiscal Q2 2025.

### Did HCWB beat earnings estimates?

No. HCW Biologics reported EPS of −$40.74 for Q2 2025 against a $10.80 estimate — a 477.22% miss.

### How much revenue did HCWB report last quarter?

HCW Biologics reported $1,310.00 in revenue for Q2 2025, against a consensus estimate of $7.0M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).